Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes

Biochemical Pharmacology

Volumn 52, Issue 10, 1996, Pages 1507-1513

  Beebe, Lisa E ^a   Roberts, Elizabeth S ^b   Fornwald, Laura W ^c   Hollenberg, Paul F ^b   Alworth, William L ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SAIC FREDERICK INC   (United States)

^d Tulane University   (United States)

Author keywords

arylalkynes; cytochrome P450; liver; lung; mouse; suicide inhibition

Indexed keywords

ALKYNE DERIVATIVE; CYTOCHROME P450 ISOENZYME;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEALKYLATION; ENZYME INHIBITION; LIVER MICROSOME; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ALKYNES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; KINETICS; LUNG; MALE; MICE; MICROSOMES; MICROSOMES, LIVER; NAPHTHALENES; OXAZINES; PHENANTHRENES; RATS; STEROID HYDROXYLASES;

EID: 0030598424     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00525-4     Document Type: Article

References (16)

1. 1. Ortiz de Montellano PR and Kunze KL, Self-catalyzed inactivation of hepatic cytochrome P450 by ethynyl substrates. J Biol Chem 255: 5578-5585, 1980.
2. 2. Hopkins NE, Foroozesh MK and Alworth WL, Suicide inhibitors of cytochrome P450 1A1 and 2B1. Biochem Pharmacol 44: 747-796, 1992.
3. 3. Alworth WL, Young-Sciame R and Hecht SS, Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inhibitors of cytochrome P450. Carcinogenesis 14: 1711-1713, 1993.
4. 4. Alworth WL, Viaje A, Sandoval A, Warren BS and Slaga TJ, Potent inhibitory effects of suicide inhibitors of P450 isozymes on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene initiated skin tumors. Carcinogenesis 12: 1209-1215, 1991.
5. 5. Hall M, Parker DK, Grover PL, Lu J-YL, Hopkins NE and Alworth WL, Effects of 1-ethynylpyrene and related inhibitors of P450 isozymes upon benzo[a]pyrene metabolism by liver microsomes. Chem Biol Interact 76: 181-192, 1990.
6. 6. Poland A, Mak I, Glover E, Boatman RJ, Ebetino F and Kende AS, 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like-inducer of microsomal monooxygenase activity. Mol Pharmacol 18: 571-580, 1980.
7. 7. Sunahara GI, Lucier GW, McCoy Z, Bresnick EH, Sanchez ER and Nelson KG, Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decreases in dexamethasone binding to rat hepatic cytosolic glucocorticoid receptor. Mol Pharmacol 36: 239-247, 1989.
8. 8. Matsubara R, Prough RA, Burke MD and Estabrook RW, The preparation of microsomal fractions of rodent respiratory tract and their characterization. Cancer Res 34: 2196-2203, 1974.
9. 9. Nerurkar PV, Park SS, Thomas PE, Nims RW and Lubet RA, Methoxyresorufin and benzyloxyresorufin: Substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46: 933-943, 1993.
10. 10. Roberts ES, Hopkins NE, Alworth WL and Hollenberg PF, Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: Identification of an active site peptide. Chem Res Toxicol 6: 470-479, 1993.
11. 11. Diwan BA, Lubet RA, Ward JM, Hrabie JA and Rice JM, Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCR and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 13: 1893-1901, 1992.
12. 12. Keith IM, Olson EB, Wilson NM and Jefcoate CR, Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450. Cancer Res 47: 1878-1882, 1987.
13. 13. Forkert PG, Vessey ML, Elce JS, Park SS, Gelboin HV and Cole SPC, Localization of phenobarbital-and 3-methylcholanthrene-inducible cytochromes P-450 in mouse lung with monoclonal antibodies. Res Commun Chem Pathol Pharmacol 53: 147-157, 1986.
14. 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Biochemistry 33: 3766-3771, 1994.
15. 15. Swanson BA, Halpert JR, Bornheim LM and Ortiz de Montellano PR, Topological analysis of the active sites of cytochromes P450IIB4 (rabbit), P450IIB10 (mouse), and P450IIB11 (dog) by in situ rearrangement of phenyl-iron complexes. Arch Biochem Biophys 292: 42-46, 1992.
16. 16. Jacob CA, Chan WK, Shepard E and Ortiz de Montellano PR, The catalytic site of rat hepatic lauric acid omega-hydroxylase. Protein versus prosthetic heme alkylation in the omega-hydroxylation of acetylenic fatty acids. J Biol Chem 263: 18640-18649, 1988.